Samuel N. Hazen - Feb 13, 2025 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: CEO, Director
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Stock symbol: HCA
Transactions as of: Feb 13, 2025
Transactions value $: -$1,526,545
Form type: 4
Date filed: 2/18/2025, 07:35 PM
Previous filing: Jan 30, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+13.2K	+20.91%	$0.00	76.4K	Feb 13, 2025	Direct	F1
transaction	HCA	Common Stock	Tax liability	-$1.53M	-4.74K	-6.21%	$321.92	71.7K	Feb 13, 2025	Direct
holding	HCA	Common Stock						813K	Feb 13, 2025	By LP
holding	HCA	Common Stock						3.01K	Feb 13, 2025	By 2023 Trust
holding	HCA	Common Stock						15K	Feb 13, 2025	By HD Trust
holding	HCA	Common Stock						16.7K	Feb 13, 2025	By 2023 GST Trust
holding	HCA	Common Stock						164K	Feb 13, 2025	By 2022 GRAT
holding	HCA	Common Stock						250K	Feb 13, 2025	By 2024 GRAT

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 28, 2022, the reporting person was granted 25,470 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

Content

On January 28, 2022, the reporting person was granted 25,470 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.